Year-end report 2007

Year-end report 2007

Key events in the fourth quarter
• New portfolio company Likvor AB
• ONCOlog Medical enters into partnership with C-RAD
• Ortoviva announces start of clinical trials 2008
• Yvonne Axelsson new CFO

Key events after the period end
• Agneta Edberg new Chief Operating Officer (COO) and Jonas Graff-Lonnevig new
VP Financial Transactions, responsible for exits

Financial information for 2007
• Results from investment activities were SEK -10.4 million (-2.5), of which SEK
-10.4 million (0.0) in the fourth quarter as a result of the write down of
LinkMed's holding in SACS Medical
• Other income amounted to SEK 5.0 million (4.0), of which SEK 1.3 million (1.3)
in the fourth quarter
• Net income/loss after tax was SEK -19.2 million (-14.5), of which SEK -13.3
million (-4.0) in the fourth quarter 
• Earnings per share was SEK -2.20 (-2.58) 
• Shareholders' equity was SEK 278.5 million (296.2) 
• Equity per share was SEK 31.93 (33.96)
• Equity/assets ratio was 98 (97) percent 
• Liquid funds amounted to SEK 125.2 million (202.7) 

Comments on 2007 from LinkMed CEO, Ingemar Lagerlöf:
“I am very pleased with the development of most of our portfolio companies last
year and would like to point out that several of them have reached important
milestones. A number of these companies have reached such a level of maturity
that it is time for us to prepare for our exit as an owner. We have therefore
strengthened our organization and I estimate that we will have carried out a
couple of exits before 2010.”


For additional information, please contact:
Ingemar Lagerlöf, CEO, cell: +46 (0)70-873 2733 or e-mail
ingemar.lagerlof@linkmed.se 
Okee Williams, Portfolio Manager, cell: +46 (0) 70- 600 5364 or e-mail
okee.williams@linkmed.se


LinkMed develops new life-science companies in collaboration with innovators. By
contributing entrepreneurship and capital, LinkMed has created a portfolio of
twelve companies, six in drug development and biotechnology and six in medical
technology. The LinkMed share is listed on the OMX Nordic Exchange, Stockholm,
and the company's largest shareholders are FastPartner, Koncentra Holding, and
the founder Ingemar Lagerlöf. See www.linkmed.se for more information.